Market Closed -
Other stock markets
|
After market 20:59:59 | |||
112.5 EUR | -0.44% | 112.6 | +0.09% |
04-24 | IPSEN : Better-than-expected Q1; guidance unchanged | |
04-24 | Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.26% | 9.96B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- IPN Stock
- News Ipsen
- Ipsen : Exelixis Say Phase 3 Trial of Cabozantinib Drug in Differentiated Thyroid Cancer Met Co-Primary Endpoint